Literature DB >> 884740

Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.

J D Vassalli, J Hamilton, E Reich.   

Abstract

The synthesis and secretion of plasminogen activator by cultured macrophages can be induced and stimulated by concanavalin A and by phorbol myristate acetate, and inhibited by such agents as glucocorticoids, mitotic inhibitors and compounds affecting cAMP metabolism. By the manipulation of stimulatory and inhibitory influences, enzyme production can be modulated continuously over a 200 fold range. In the same way, the proportion of cells that secrete detectable levels of enzyme can be varied from 1-90%. No comparable modulation of lysozyme or acid hydrolase production is observed under the same conditions. These results suggest that the physiological control of macrophage plasminogen activator production is achieved by the interacting effects of mutually antagonistic stimuli; this emphasizes the utility of this enzyme for the study of regulatory phenomena, including those relating to inflammation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884740     DOI: 10.1016/0092-8674(77)90086-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  49 in total

1.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.

Authors:  T H Bugge; M J Flick; M J Danton; C C Daugherty; J Romer; K Dano; P Carmeliet; D Collen; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Authors:  A M Henney; P R Wakeley; M J Davies; K Foster; R Hembry; G Murphy; S Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Basic fibroblast growth factor induces angiogenesis in vitro.

Authors:  R Montesano; J D Vassalli; A Baird; R Guillemin; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Production of plasminogen activator in cultures of superior cervical ganglia and isolated Schwann cells.

Authors:  A Alvarez-Buylla; J E Valinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  cDNA and gene nucleotide sequence of porcine plasminogen activator.

Authors:  Y Nagamine; D Pearson; M S Altus; E Reich
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

6.  Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices.

Authors:  R M Robinson; R E Taylor; H Birkedal-Hansen
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

7.  Release of fibrinolytic activators from the cornea and conjunctiva.

Authors:  E Lantz; A Andersson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

8.  Sensitive assay for plasminogen activator of transformed cells.

Authors:  H Y Liu; G A Peltz; S P Leytus; C Livingston; J Brocklehurst; W F Mangel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Catabolism of 2-deoxyglucose by phagocytic leukocytes in the presence of 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  P Zabos; D Kyner; N Mendelsohn; C Schreiber; S Waxman; J Christman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

10.  Tumor promoters increase the synthesis of a 32,000-dalton protein in BALB/c 3T3 cells.

Authors:  T Hiwasa; S Fujimura; S Sakiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.